Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59°N [3]

AIDS

Volumn 20, Issue 14, 2006, Pages 1906-1907

  Gyllensten, Katarina ^a   Josephson, Filip ^a   Lidman, Knut ^a   Sääf, Maria ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ;

ANAMNESIS; CASE REPORT; CLINICAL FEATURE; HUMAN; HYDROXYLATION; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; VITAMIN D DEFICIENCY;

ANTI-HIV AGENTS; BENZOXAZINES; CYTOCHROME P-450 ENZYME SYSTEM; HIV INFECTIONS; HUMANS; MALE; OXAZINES; VITAMIN D DEFICIENCY;

EID: 33748500419     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000244216.08327.39     Document Type: Letter

References (18)

1. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 2003; 17:1917-1923.
2. Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G, et al. Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS 2001; 15:137-138.
3. Tebas P, PowderlyWG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000; 14:F63-F67.
4. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, et al. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 2003; 36:482-490.
5. Knobel H, Guelar A, Vallecillo G, Nogues X, Diez A. Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 2001; 15:807-808.
6. Al Faraj S, Al Mutairi K. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine 2003; 28:177-179.
7. Plotnikoff GA, Quigley J. Prevalence of severe hypovitaminosis D in patients with persistent nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463-1470.
8. Zenkert-Andersson K, Hedeland H, Manhem P. Too little exposure to sun may cause vitamin D deficiency. Muslim women in Sweden are a risk group [in Swedish]. Läkartidningen 1996; 46:4153-4155.
9. Glerup H. Vitamin D deficiency among immigrants [in Danish]. Ugeskrift Laeger 2000; 162:6196-6199.
10. Wikvall K. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form [Review]. Int J Mol Med 2001; 7:201-209.
11. Gupta RP, Hollis BW, Patel SB, Patrick KS, Bell NH. CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res 2004; 19:680-688.
12. Pascussi JM, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005; 115:177-186.
13. Haripasad N, Nallani SC, Sane RS, Buckley DJ, Buckley AR, Desai PB. Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital. J Clin Pharmacol 2004; 44:1273-1281.
14. Hahn TJ, Hendin BA, Scharp CR, Haddad JG. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 1972; 287:900-903.
15. Bouillon R, Reynaert J, Claes JH, Lissens W, De Moor P. The effect of anticonvulsant therapy on serum levels of 25-hydrosy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab 1975; 41:1130-1135.
16. Kulak CA, Borba VZ, Bilezikian JP, Silvado CE, Paola L, Boguszewski CL. Bone mineral density and serum levels of 25OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004; 62:940-948.
17. Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. QJ Nucl Med Mol Imaging 2004; 48:39-48.
18. Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 2003; 17:513-520.